AAPG Stock Summary and Trading Ideas (Ascentage Pharma Group International - American Depository Shares | NASDAQ:AAPG)

Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The Group has one reportable operating segment, which is discovering, developing, and commercializing therapies to address medical needs in hematological malignancies and currently has seven drug candidates in pipeline under research. The company's geographical segments include the United States and Mainland China.

Ascentage Pharma Group International - American Depository Shares trades on the NASDAQ stock market under the symbol AAPG.

As of October 8, 2026, AAPG stock price declined to $14.55 with 7,635 million shares trading.

AAPG has a market cap of $1.36 billion. This is considered a Small Cap stock.

Last quarter Ascentage Pharma Group International - American Depository Shares reported $45 million in Revenue and -$.32 earnings per share. This beat revenue expectation by $20 million and exceeded earnings estimates by $.12.

AAPG has underperformed the market in the last year with a price return of -62.6% while the SPY ETF gained +16.8%. AAPG has also underperformed the stock market ETF in the last 3 month and 2 week periods returning -22.1% and -6.6%, respectively, while the SPY returned +3.8% and +0.8%, respectively.

AAPG support price is $14.27 and resistance is $15.61 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AAPG shares will trade within this expected range on the day.